Latest

Block: Can Management Execute On A Good Plan? (Archive)

Waiting for proof of execution before buying into Block’s ambitious workforce reset.

Pfizer: Paying Too Much To Boost Revenues (Archive)

Pfizer’s rich M&A bets risk turning Seagen into an expensive capital allocation mistake.

PayPal: Too Many Issues To Reckon With (Archive)

PayPal’s growth and margins look fragile, making today’s cheap valuation a value trap risk.

Annaly Capital: Set To Rise From Falling Rates (Archive)

Annaly is positioned to revive book value as falling rates restore net interest margins.

Alibaba: Still Not A Buy (Archive)

Alibaba remains cheap but uninspiring without clear growth or catalyst-driven momentum.

Berkshire Hathaway: Do As Buffett Says Not As He Does (Archive)

Berkshire now looks fairly valued but faces worsening cash flows and looming underperformance.

CompX International: A Solid Company On The Cusp Of A Growth Recovery (Archive)

CompX rides rebounding locks and marine demand with upside as the cycle normalizes.